Abstract
Paracoccidioidomycosis (PCM) represents the most frequent systemic mycosis in Latin American. The disease is caused by the pathogenic thermally dimorphic fungus Paracoccidioides brasiliensis, and is initially characterized by pulmonary lesions, which can subsequently disseminate to other organs, resulting in secondary injuries. Although its high incidence, there is no commercially available vaccine against fungal diseases. A novel strategy, using Saccharomyces cerevisiae yeast as a vehicle for immunization against PCM, was recently successfully described. Herein, we describe strategies for the construction of the suitable S. cerevisiae vaccine, and protocols of administration and evaluation of the efficacy of the vaccine against experimental PCM.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Capilla J, Clemons KV, Liu M, Levine HB, Stevens DA (2009) Saccharomyces cerevisiae as a vaccine against coccidioidomycosis. Vaccine 27:3662–3668
Liu M, Clemons KV, Johansen ME, Martinez M, Chen V et al (2012) Saccharomyces as a vaccine against systemic candidiasis. Immunol Invest 41:847–855
Liu M, Capilla J, Johansen ME, Alvarado D, Martinez M et al (2011) Saccharomyces as a vaccine against systemic aspergillosis:‘the friend of man’ a friend again? J Med Microbiol 60:1423–1432
Majumder T, Liu M, Chen V, Martinez M, Alvarado D et al (2014) Killed Saccharomyces cerevisiae protects against lethal challenge of Cryptococcus grubii. Mycopathologia 178:189–195
Luo G, Gebremariam T, Clemons KV, Stevens DA, Ibrahim AS (2014) Heat-killed yeast protects diabetic ketoacidotic-steroid treated mice from pulmonary mucormycosis. Vaccine 32:3573–3576
Assis-Marques MA, Oliveira AF, Ruas LP, dos Reis TF, Roque-Barreira MC et al (2015) Saccharomyces cerevisiae expressing Gp43 protects mice against Paracoccidioides brasiliensis infection. PLoS One 10:e0120201
Ardiani A, Higgins JP, Hodge JW (2010) Vaccines based on whole recombinant Saccharomyces cerevisiae cells. FEMS Yeast Res 10:1060–1069
Grocott RG (1955) A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic. Am J Clin Pathol 25(8):975–979
Hartley JL, Temple GF, Brasch MA (2000) DNA cloning using in vitro site-specific recombination. Genome Res 10:1788–1795
Green M, Sambrook J (2012) Molecular cloning, a laboratory manual, 4th edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Xiao W (ed) (2006) Yeast protocols in molecular biology protocols. Humana Press
Kashino SS, Calich VL, Burger E, Singer-Vermes LM (1985) In vivo and in vitro characteristics of six Paracoccidioides brasiliensis strains. Mycopathologia 92(3):173–178
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Oliveira, A.F., Coelho, P.S.R. (2017). Yeast Expressing Gp43 Protein as a Vaccine Against Paracoccidioides brasiliensis Infection. In: Kalkum, M., Semis, M. (eds) Vaccines for Invasive Fungal Infections. Methods in Molecular Biology, vol 1625. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7104-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7104-6_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7103-9
Online ISBN: 978-1-4939-7104-6
eBook Packages: Springer Protocols